awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36858958-6A2098E3-8C17-4920-8613-4828C90DBAC7
Q36858958-6A2098E3-8C17-4920-8613-4828C90DBAC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36858958-6A2098E3-8C17-4920-8613-4828C90DBAC7
6-weekly bevacizumab versus 4-weekly ranibizumab for neovascular age-related macular degeneration: a 2-year outcome.
P2860
Q36858958-6A2098E3-8C17-4920-8613-4828C90DBAC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36858958-6A2098E3-8C17-4920-8613-4828C90DBAC7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
68c0c1af998640ce1229176f287658d8413122dd
P2860
Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans.